Galentic Pharma India

What Galentic Pharma India does

Galentic Pharma (India) Pvt. Ltd. is a privately held pharmaceutical manufacturer established in 1992 and headquartered in Mumbai, India, specializing in semi-solid Finished Dosage Forms (FDFs) across two therapeutic platforms: sterile ophthalmic products (ointments and gels) and non-sterile dermatological products (creams, ointments, lotions, emulsions, gels, and medicated shampoos). The company operates two manufacturing facilities — Manufacturing Unit I in Navi Mumbai (Rabale MIDC) and Manufacturing Unit II in the Kandla Special Economic Zone, Gandhidham, Gujarat — supported by a DSIR-recognized, 5,000 sq. ft. R&D Centre in Andheri (East) Mumbai covering pre-formulation, formulation, analytical development, microbiology, and In-vitro Release Testing (IVRT) using 21 CFR-compliant HPLC/GC systems. Its product catalog of more than 80 SKUs addresses antibacterial, antifungal, anti-inflammatory, analgesic, anti-hemorrhoid, scabicide, and ocular surface disease indications, with regulatory clearances spanning US FDA cGMP, WHO-GMP, ISO 13485:2016, ISO 9001:2015, Health-Canada, and PIC/S-Malaysia.

The company generates revenue through direct B2B manufacturing and export of pharmaceutical products to international distributors and institutional buyers, leveraging trade show presence at events such as iPHEX 2026 and CPHI Milan 2026 for top-of-funnel demand generation. Pricing is quote-based and not publicly disclosed. The customer base is described at the use-case level — ophthalmic and dermatological healthcare providers — with no named end-customer logos or distributor-level revenue data available. Recent strategic activity includes a minority investment in Pandorum Technologies' $18 million Series B (announced 2026-02-09), linking the firm to exosome-based ocular regenerative therapies. Ownership is private with no disclosed PE/VC backing, parent entity, or external investor base, and the company employs 251-500 people across its Mumbai offices and two manufacturing sites.

Name

Galentic Pharma India

Legal name

Galentic Pharma (India) Pvt. Ltd.

Website

https://galentic.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

251–500 employees

Short description

Galentic Pharma (India) Pvt. Ltd. is a privately held Mumbai-based pharmaceutical manufacturer founded in 1992 that produces over 80 sterile ophthalmic and non-sterile dermatological semi-solid FDFs, exporting globally to institutional buyers from two Indian manufacturing facilities.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Sterile ophthalmic manufacturing
• Dermatological topical formulations
• Pharmaceutical contract manufacturing
• Semi-solid dosage forms
• Medicated shampoo production

Headquarters

HQ city

Andheri

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Manufacturing & Sales: Manufacturing and sale of sterile ophthalmic products (ointments, gels) and non-sterile dermatological products (creams, ointments, lotions, emulsions, gels, medicated shampoos). Products are sold globally through export channels to healthcare providers and pharmaceutical distributors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Galentic Pharma manufactures semi-solid Finished Dosage Forms (FDFs) with specialization in sterile ophthalmic products (ointments and gels) and non-sterile dermatological topicals (creams, ointments, lotions, emulsions, gels, and medicated shampoos). The company operates two world-class manufacturing facilities in India and exports over 80 pharmaceutical products to global markets under multiple regulatory certifications including US FDA cGMP, WHO-GMP, and ISO 13485.

Product overview

Galentic Pharma India is a pharmaceutical manufacturer specializing in semi-solid Finished Dosage Forms (FDFs). The company operates two world-class manufacturing facilities and produces over 80 products across three main categories: (1) Sterile Ophthalmic Products including ointments and gels for treating eye infections, inflammation, and dry eye conditions, with brands such as Netravir, Kloraxin, Triosporin, Bromycin, Galmoxcin, and Siccagel; (2) Non-Sterile Dermatological Products including topical creams, ointments, gels, lotions, emulsions, and solutions for treating fungal infections, inflammatory skin conditions, bacterial infections, and hemorrhoids, with brands such as Candigen, Fungigen, Derm Keta, Dermosone, Netracort, Derm-Clobeta, and Silvadex; and (3) Medicated Shampoos for treating dandruff and scalp infections, with brands such as Seldruf and Derm Keta. The company also manufactures sterile topical products including anesthetic jellies.

Differentiator

Problem solved

Functional benefit

Products and services

• Sterile Ophthalmic Ointments and Gels
• Non-Sterile Dermatological Topical Products
• Medicated Shampoos
• Sterile Topical Anesthetic Products
• Antiseptic Hand Scrub

Quantifiable outcome

• Over 80 products manufactured across ophthalmic and dermatological categories

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Bausch + Lomb: Global eye-health company with a portfolio that includes ophthalmic ointments, gels, and lubricants directly overlapping with Galentic's sterile ophthalmic range. Comparable in ophthalmic finishing and global distribution, though via branded consumer/prescription channels rather than B2B export.
• Sun Pharma: India's largest pharma company with a dominant global dermatology franchise (Taro acquisition) and growing specialty/ophthalmic presence. Overlaps in topical semi-solid dosage forms and US FDA-approved manufacturing, though at vastly larger scale.
• Cipla: One of India's largest generic pharmaceutical exporters with global manufacturing footprint and a deep ophthalmic and dermatology portfolio. Comparable product categories and export-led B2B model, but at substantially greater scale, breadth, and brand recognition.
• Alcon: Global leader in ophthalmic surgery and pharmaceuticals, including a substantial ophthalmic drops and ointments business. Comparable in sterile ophthalmic product category, though Alcon's focus and capability profile (surgical, IOLs, branded ophthalmic pharma) is far broader than Galentic's semi-solid niche.

Direct peers

• Glenmark Pharmaceuticals: Major Indian generics player with a sizable dermatology franchise and growing ophthalmic business, distributing across 80+ countries. Comparable product overlap in topical antifungals, corticosteroids, and dermatological creams/ointments, though at considerably larger scale.
• FDC Limited: Indian manufacturer specializing in ophthalmic, dermatological, and topical formulations with significant export presence. Closely comparable category alignment (sterile ophthalmics + dermatology semi-solids) and similar mid-sized contract/manufacturing profile.
• Ajanta Pharma: Indian specialty pharmaceutical manufacturer with a strong dermatology and ophthalmic portfolio, exporting to regulated and emerging markets. Highly comparable as a mid-sized Indian FDF player with overlapping semi-solid dermatology and ophthalmic categories and global distribution focus.
• Mankind Pharma: India's largest domestic pharma by prescriptions and a leading dermatology franchise operator. Comparable in topical dermatology (antifungals, corticosteroids, antibacterials) and increasingly in ophthalmics, though with much broader primary-care presence.

Emerging players

• Entod Pharmaceuticals: India-based ophthalmic specialist pharma manufacturer with a portfolio concentrated in eye care products. Directly comparable in Indian ophthalmic FDF manufacturing focus and export orientation, sitting closer to Galentic in size and category depth.
• Akorn Operating Company: US specialty pharmaceutical company focused on ophthalmic and topical prescription products, with manufacturing capabilities relevant to sterile ophthalmic ointments and gels. Comparable in ophthalmic topical sterile FDFs but operates with significantly different scale and geography.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/galentic-pharma-india-pvt.-ltd.

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Galentic Pharma India